ICU Medical (NASDAQ:ICUI – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its peers? We will compare ICU Medical to related businesses based on the strength of its dividends, risk, valuation, analyst recommendations, earnings, profitability and institutional ownership.
Insider & Institutional Ownership
96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 2.1% of ICU Medical shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Risk & Volatility
ICU Medical has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Comparatively, ICU Medical’s peers have a beta of 2.57, suggesting that their average share price is 157% more volatile than the S&P 500.
Profitability
This table compares ICU Medical and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ICU Medical | 2.76% | 8.40% | 4.51% |
| ICU Medical Competitors | -304.20% | -315.07% | -22.11% |
Earnings & Valuation
This table compares ICU Medical and its peers revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| ICU Medical | $2.23 billion | $730,000.00 | 74.59 |
| ICU Medical Competitors | $1.89 billion | $136.81 million | 5.76 |
ICU Medical has higher revenue, but lower earnings than its peers. ICU Medical is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Analyst Recommendations
This is a breakdown of current recommendations for ICU Medical and its peers, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ICU Medical | 0 | 3 | 4 | 2 | 2.89 |
| ICU Medical Competitors | 4290 | 10574 | 18359 | 830 | 2.46 |
ICU Medical presently has a consensus price target of $195.20, suggesting a potential upside of 9.50%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 20.77%. Given ICU Medical’s peers higher possible upside, analysts plainly believe ICU Medical has less favorable growth aspects than its peers.
Summary
ICU Medical beats its peers on 8 of the 13 factors compared.
About ICU Medical
ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.
